tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Tarsus Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
PremiumCompany AnnouncementsTarsus Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
3M ago
Tarsus Pharmaceuticals: Strong Market Performance and Growth Potential Justify Buy Rating
Premium
Ratings
Tarsus Pharmaceuticals: Strong Market Performance and Growth Potential Justify Buy Rating
3M ago
Strong Market Position and Growth Potential Drive Buy Rating for Tarsus Pharmaceuticals
Premium
Ratings
Strong Market Position and Growth Potential Drive Buy Rating for Tarsus Pharmaceuticals
3M ago
Promising Growth and Market Penetration of XDEMVY Drives Buy Rating and Increased Price Target
PremiumRatingsPromising Growth and Market Penetration of XDEMVY Drives Buy Rating and Increased Price Target
4M ago
Tarsus Pharmaceuticals price target raised to $88 from $72 at H.C. Wainwright
Premium
The Fly
Tarsus Pharmaceuticals price target raised to $88 from $72 at H.C. Wainwright
4M ago
Tarsus Pharmaceuticals price target raised to $85 from $80 at BofA
Premium
The Fly
Tarsus Pharmaceuticals price target raised to $85 from $80 at BofA
4M ago
Tarsus Pharmaceuticals reports Q2 EPS (48c), consensus (36c)
PremiumThe FlyTarsus Pharmaceuticals reports Q2 EPS (48c), consensus (36c)
6M ago
Short Report: Grindr shorts at record highs as CFO quits before earnings
Premium
The Fly
Short Report: Grindr shorts at record highs as CFO quits before earnings
7M ago
Tarsus Pharmaceuticals Holds Annual Stockholders Meeting
Premium
Company Announcements
Tarsus Pharmaceuticals Holds Annual Stockholders Meeting
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100